Calretinin as a blood-based biomarker for mesothelioma

BACKGROUND: Malignant mesothelioma (MM) is a deadly cancer mainly caused by previous exposure to asbestos. With a latency period up to 50 years the incidence of MM is still increasing, even in countries that banned asbestos. Secondary prevention has been established to provide persons at risk regula...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Johnen, Georg, Gawrych, Katarzyna, Raiko, Irina, Casjens, Swaantje, Pesch, Beate, Weber, Daniel G., Taeger, Dirk, Lehnert, Martin, Kollmeier, Jens, Bauer, Torsten, Musk, Arthur W., Robinson, Bruce W. S., Brüning, Thomas, Creaney, Jenette
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5450182/
https://ncbi.nlm.nih.gov/pubmed/28558669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3375-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados